You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 21, 2024

Waylis Therap Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Waylis Therap
International Patents:24
US Patents:1
Tradenames:11
Ingredients:11
NDAs:11

Drugs and US Patents for Waylis Therap

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Waylis Therap ACIPHEX rabeprazole sodium TABLET, DELAYED RELEASE;ORAL 020973-001 May 29, 2002 DISCN Yes No ⤷  Sign Up ⤷  Sign Up
Waylis Therap VALIUM diazepam TABLET;ORAL 013263-006 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up
Waylis Therap COREG carvedilol TABLET;ORAL 020297-001 Sep 14, 1995 AB RX Yes No ⤷  Sign Up ⤷  Sign Up
Waylis Therap VALIUM diazepam TABLET;ORAL 013263-002 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up
Waylis Therap COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-003 Oct 20, 2006 AB RX Yes Yes 8,101,209*PED ⤷  Sign Up Y ⤷  Sign Up
Waylis Therap COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-002 Oct 20, 2006 AB RX Yes No 8,101,209*PED ⤷  Sign Up Y ⤷  Sign Up
Waylis Therap MYLERAN busulfan TABLET;ORAL 009386-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Waylis Therap

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Waylis Therap LUNESTA eszopiclone TABLET;ORAL 021476-002 Dec 15, 2004 6,444,673*PED ⤷  Sign Up
Waylis Therap COREG carvedilol TABLET;ORAL 020297-001 Sep 14, 1995 5,902,821*PED ⤷  Sign Up
Waylis Therap COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-002 Oct 20, 2006 RE40000*PED ⤷  Sign Up
Waylis Therap COREG carvedilol TABLET;ORAL 020297-004 May 29, 1997 5,760,069*PED ⤷  Sign Up
Waylis Therap COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-004 Oct 20, 2006 5,760,069*PED ⤷  Sign Up
Waylis Therap COREG carvedilol TABLET;ORAL 020297-002 Sep 14, 1995 5,760,069*PED ⤷  Sign Up
Waylis Therap JALYN dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 022460-001 Jun 14, 2010 5,998,427 ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for WAYLIS THERAP drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Capsules 10 mg and 20 mg ➤ Subscribe 2008-03-18
➤ Subscribe Extended-release Capsules 80 mg ➤ Subscribe 2007-11-19
➤ Subscribe Capsule 0.5 mg/0.4 mg ➤ Subscribe 2010-10-26
➤ Subscribe Extended-release Capsules 40 mg ➤ Subscribe 2007-12-21
➤ Subscribe Capsules 0.5 mg ➤ Subscribe 2007-10-29
➤ Subscribe Tablets 1 mg, 2 mg and 3 mg ➤ Subscribe 2008-12-15

International Patents for Waylis Therap Drugs

Country Patent Number Estimated Expiration
China 100341493 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2005099671 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 03030878 ⤷  Sign Up
South Korea 101078636 ⤷  Sign Up
European Patent Office 1744729 ⤷  Sign Up
Japan 2007532689 ⤷  Sign Up
Brazil PI0213175 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for Waylis Therap Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0719278 SPC/GB03/018 United Kingdom ⤷  Sign Up PRODUCT NAME: DUTASTERIDE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SOLVATE.; REGISTERED: SE 17871 20020719; SE 17872 20020719; UK PL 19494/0005 20030117; UK PL 19494/0006 20030117
0268956 1999C0030 Belgium ⤷  Sign Up PRODUCT NAME: RABEPRAZOLE SODIUM; NAT. REGISTRATION NO/DATE: 5532 IE 1 F 3 19990201; FIRST REGISTRATION: GB 10555/0010 19980508
0719278 23/2003 Austria ⤷  Sign Up PRODUCT NAME: DUTASTERIDE, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SOLVATES; NAT. REGISTRATION NO/DATE: 1-24844, 1-24845 20030217; FIRST REGISTRATION: SE 17871, 17872 20020719
0268956 SPC/GB98/040 United Kingdom ⤷  Sign Up PRODUCT NAME: RABEPRAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE SODIUM SALT; REGISTERED: UK 10555/0010 19980508; UK 10555/0008 19980508
0719278 03C0030 France ⤷  Sign Up PRODUCT NAME: DUTASTERIDE; NAT. REGISTRATION NO/DATE: NL 28 131 20030327; FIRST REGISTRATION: SE - 17 871 20020719
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.